Navigation Links
DJO Incorporated's Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
Date:8/19/2007

SAN DIEGO and AUSTIN, Texas, Aug. 16 /PRNewswire/ -- DJO Incorporated (NYSE: DJO), a global provider of products and services that promote musculoskeletal and vascular health, today reported that on August 9, 2007, the U.S. Federal Trade Commission ("FTC") granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, for the proposed acquisition of DJO by an affiliate of ReAble Therapeutics, Inc. ("ReAble").

On July 16, 2007, DJO announced that it had entered into an agreement and plan of merger under which an affiliate of ReAble will acquire all outstanding shares of DJO's common stock for a cash payment of $50.25 per share. An affiliate of The Blackstone Group ("Blackstone") is the controlling shareholder of ReAble. On July 27, 2007, DJO and Blackstone submitted pre-merger notification and report forms with the FTC and the United States Department of Justice, Antitrust Division. The granting of early termination of the waiting period means the proposed acquisition has cleared U.S. antitrust review, but remains subject to satisfaction of several other conditions, including approval of the transaction by DJO's stockholders and the expiration or termination of the waiting period under the German Act Against Restraints of Competition.

Additional Information and Where to Find It

In connection with the proposed transaction, DJO intends to file a proxy statement with the Securities and Exchange Commission (the "SEC"). STOCKHOLDERS ARE URGED TO READ THE PROXY STATEMENT (AND ALL AMENDMENTS AND SUPPLEMENTS TO IT) AND OTHER MATERIALS THAT THE COMPANY MAY FILE WITH THE SEC IN THEIR ENTIRETY WHEN SUCH MATERIALS BECOME AVAILABLE, BECAUSE THE MATERIALS
'/>"/>

SOURCE ReAble Therapeutics Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related biology technology :

1. Doyle urges support of higher education spending
2. Doyle outlines spending for Medical College, UWM
3. Chippewa Valley to get $46 million in defense spending
4. In public attitudes about taxes and spending, Wisconsin is Jekyll and Hyde
5. Audit of multi-million dollar state IT spending will proceed
6. Stratagene sets aside $21M to pay Third Wave pending appeal
7. New report says Wisconsin R&D spending exceeding expectations
8. IT Spending to Increase in Second Half of 2003
9. Technology and mergers: Getting the strategic applications
10. AT&T - BellSouth merger: Revestiture continues
11. CDW names VP to handle Berbee merger
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2015)... - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ICO) ... quarter ended June 30, 2015. Amounts, unless specified ... under International Financial Reporting Standards ("IFRS"). ... Oral Amp B program, rapidly advancing towards the ... Rae , President & CEO of iCo Therapeutics. "We ...
(Date:8/26/2015)... 26, 2015  Platform therapeutic company Symic Biomedical, ... a $1.5M Phase II SBIR grant from the ... its therapeutic agent to reduce arteriovenous fistula (AVF) ... stage renal disease (ESRD) patients undergoing hemodialysis. The ... Diabetes and Digestive and Kidney Diseases (NIDDK), will ...
(Date:8/26/2015)... 2015 After litigating and negotiating patent ... to P2i United States patent RE43,651 ... the United States without any admission ... either party. As a result of the parties, settlement, the ... California dismissed the case without prejudice. ...
(Date:8/25/2015)... Aug. 25, 2015   WuXi PharmaTech (Cayman) Inc. ... and technology platform company serving the pharmaceutical, biotechnology, and ... Pharm," Hong Kong Exchange Stock Code: 0950), a research-based ... with 20 years of operations in ... have signed an agreement whereby WuXi,s Laboratory Testing Division ...
Breaking Biology Technology:iCo Therapeutics Announces Second Quarter 2015 Financial Results 2iCo Therapeutics Announces Second Quarter 2015 Financial Results 3Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 3P2i Settles United States Litigation 2WuXi PharmaTech to Be Exclusive Supplier of Laboratory Testing Services to Lee's Pharm 2WuXi PharmaTech to Be Exclusive Supplier of Laboratory Testing Services to Lee's Pharm 3
... HILLS, Mass., Aug. 4 Joseph F. Finn, Jr.,C.P.A. ... had been assigned to him on July 28, 2008 ... of Creditors is a common law,procedure, wherein Finn will ... means of a sealed bid auction on October 10, ...
... Calif., Aug. 4 /Xinhua-PRNewswire-FirstCall/ --,Kiwa Bio-Tech Products ... Kiwa Bio-Tech Products (Shandong) Co., Ltd. (Kiwa ... the China Organic Food,Certification Center (COFCC)., ... and appraisal of,Kiwa Shandong,s products, the China ...
... HUBBARD, Ohio, Aug. 4 NanoLogix, Inc. (OTC:,NNLX) ... following updates:, NanoLogix and CL Solutions ... develop and market Fast Detection Bioremediation,Kits (FDBK) for ... in soil and groundwater. Efrain Torres, CEO of ...
Cached Biology Technology:Kiwa Bio-Tech Receives Nationally Recognized Organic Products Certification 2Kiwa Bio-Tech Receives Nationally Recognized Organic Products Certification 3NanoLogix Inc. Announces Joint Development With CL Solutions and First Sales of Rapid Detection Kits 2NanoLogix Inc. Announces Joint Development With CL Solutions and First Sales of Rapid Detection Kits 3
(Date:7/31/2015)... juli 2015 Den 10. internationale konference om ... den 22. - 25. oktober i Shenzhen ... 10-års fødselsdag i år. Siden starten i 2006 er ... på ,omik,-feltet, og er en af de mest dynamiske, ... fokuserer på nylige gennembrud og fremskridt inden for ,omik,-forskning, ...
(Date:7/31/2015)... juillet 2015 La 10e Conférence internationale ... organisée par le BGI du 22 au 25 ... en Chine. La conférence célèbre son ... 2006, l,ICG est devenue l,une des réunions annuelles ... « omiques » et c,est aussi la plus dynamique, la ...
(Date:7/31/2015)... OXFORD, Conn. , Jul. 31, 2015 NXT-ID, ... a biometric authentication company focused on the growing mobile ... announces that it has filed provisional patent 62/198989 for ... This invention highlights a method to advance crypto-currencies ... technology by introducing a common, uniform way to manage ...
Breaking Biology News(10 mins):Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 2La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 3NXT-ID Patents Electronic Crypto-Currency Management Technology 2NXT-ID Patents Electronic Crypto-Currency Management Technology 3NXT-ID Patents Electronic Crypto-Currency Management Technology 4
... no exception to the general rule among mammals that ... of Alberta researcher David Coltman has found a genetic ... about their romantic partners. Big, heavy males mountain ... for themselves. The larger males pass their physical attributes ...
... Singapore,s leading science and technology university is ... in top-level research and in student and faculty/staff ... in Turkey. This first-ever partnership between Nanyang ... see collaboration in joint research activities, including organising ...
... if you are not a cook, you might have wondered ... into a bowl of water will disperse in a dramatic ... Singh, PhD, a mechanical engineering professor at NJIT who has ... about it, but can explain why. He says ...
Cached Biology News:NTU ramps up international research -- inks deals with 4 leading Turkish universities 2NTU ramps up international research -- inks deals with 4 leading Turkish universities 3NJIT engineer discovers why particles disperse on liquids 2
... FP Standardization Kit is used to ... polarization values of fluorescein solutions to ... System. It also allows users to ... their instrument to the expected values ...
Whole blood is collected from mice (Swiss Webster, 8-10 weeks old,either sex) and processed within 45 minutes of collection. The complement is then filtered and pooled on ice, bottled and stored at -...
Whole blood is collected from healthy guinea pigs of either sex from US source which are free of visible diseases at time of blood collection. Hemolytic titer: CH50 = 435 units...
Luminometers...
Biology Products: